A Phase II Study of Gemcitabine, Vincristine, and Cisplatin (Gvp) As Second-Line Treatment for Patients with Advanced Soft Tissue Sarcoma

Patients with advanced soft tissue sarcoma (aSTS) typically have a poor prognosis. Patients progressing to doxorubicin-based regimen have limited therapeutic options. Monotherapy with cytotoxic drugs appears to have only modest activity in the second-line setting. The purpose of this phase II study...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Medicine (Baltimore)
Autori principali: Luo, Zhiguo, Zhang, Xiaowei, Peng, Wei, Wu, Xianghua, Wang, Huijie, Yu, Hui, Wang, Jialei, Chang, Jianhua, Hong, Xiaonan
Natura: Artigo
Lingua:Inglês
Pubblicazione: Wolters Kluwer Health 2015
Soggetti:
5700
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4985388/
https://ncbi.nlm.nih.gov/pubmed/26512574
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000001777
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi